Matches in SemOpenAlex for { <https://semopenalex.org/work/W180688080> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W180688080 endingPage "4" @default.
- W180688080 startingPage "140" @default.
- W180688080 abstract "To verify the possibility of a concomitant therapy control in 31 patients (18 psoriatic arthritis [PA], 13 rheumatoid arthritis [RA]) the blood cell concentration of Methotrexate (MTX) was continuously measured over a period of 6 months. The determinations were carried out by using a RIA of the CIS Corp. At any time MTX was determined laboratory and clinical examinations were done and the P-III-P serum-level was measured by using a RIA of the Behringwerke. The cellular MTX showed to be statistically significantly elevated compared to baseline, whereas within ranges of total cumulative dosages only insignificant fluctuations could be noticed. Like in the treatment of Psoriasis a strict correlation between the weekly administered dose and the cellular MTX could be established, the total cumulative dose, however, had no influence on the cellular MTX-level. In the treatment of RA slightly higher weekly dosages were necessary, which caused significantly higher cellular MTX concentrations in RA patients. Some correlations between clinical as well as serological parameters of disease activity could be noticed, nevertheless they do not allow distinct interpretations. In both diseases a significant relationship between the cellular MTX-level and the P-III-P serum-level could be realized. A storage of MTX in blood cells, especially in erythrocytes, seems to be evident. To reach therapeutical benefit in RA slightly higher mean dosages may be necessary. A therapy monitoring by the means of continuous determinations of cellular MTX seems to be impossible. In contrast an approach to the early detection of liver fibrosis can be given by the correlation between cellular MTX and the P-III-P serum levels." @default.
- W180688080 created "2016-06-24" @default.
- W180688080 creator A5000240656 @default.
- W180688080 creator A5000284511 @default.
- W180688080 creator A5028756742 @default.
- W180688080 creator A5049296865 @default.
- W180688080 creator A5051047128 @default.
- W180688080 creator A5063335881 @default.
- W180688080 creator A5078467243 @default.
- W180688080 creator A5079956332 @default.
- W180688080 date "1988-01-01" @default.
- W180688080 modified "2023-09-23" @default.
- W180688080 title "[Blood cell concentration of methotrexate in long-term therapy of inflammatory rheumatic diseases]." @default.
- W180688080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3146207" @default.
- W180688080 hasPublicationYear "1988" @default.
- W180688080 type Work @default.
- W180688080 sameAs 180688080 @default.
- W180688080 citedByCount "2" @default.
- W180688080 crossrefType "journal-article" @default.
- W180688080 hasAuthorship W180688080A5000240656 @default.
- W180688080 hasAuthorship W180688080A5000284511 @default.
- W180688080 hasAuthorship W180688080A5028756742 @default.
- W180688080 hasAuthorship W180688080A5049296865 @default.
- W180688080 hasAuthorship W180688080A5051047128 @default.
- W180688080 hasAuthorship W180688080A5063335881 @default.
- W180688080 hasAuthorship W180688080A5078467243 @default.
- W180688080 hasAuthorship W180688080A5079956332 @default.
- W180688080 hasConcept C126322002 @default.
- W180688080 hasConcept C151032500 @default.
- W180688080 hasConcept C162156334 @default.
- W180688080 hasConcept C203014093 @default.
- W180688080 hasConcept C2776260265 @default.
- W180688080 hasConcept C2777077863 @default.
- W180688080 hasConcept C2777575956 @default.
- W180688080 hasConcept C2779384505 @default.
- W180688080 hasConcept C2780564577 @default.
- W180688080 hasConcept C2781059491 @default.
- W180688080 hasConcept C71924100 @default.
- W180688080 hasConcept C90924648 @default.
- W180688080 hasConcept C98274493 @default.
- W180688080 hasConceptScore W180688080C126322002 @default.
- W180688080 hasConceptScore W180688080C151032500 @default.
- W180688080 hasConceptScore W180688080C162156334 @default.
- W180688080 hasConceptScore W180688080C203014093 @default.
- W180688080 hasConceptScore W180688080C2776260265 @default.
- W180688080 hasConceptScore W180688080C2777077863 @default.
- W180688080 hasConceptScore W180688080C2777575956 @default.
- W180688080 hasConceptScore W180688080C2779384505 @default.
- W180688080 hasConceptScore W180688080C2780564577 @default.
- W180688080 hasConceptScore W180688080C2781059491 @default.
- W180688080 hasConceptScore W180688080C71924100 @default.
- W180688080 hasConceptScore W180688080C90924648 @default.
- W180688080 hasConceptScore W180688080C98274493 @default.
- W180688080 hasIssue "5" @default.
- W180688080 hasLocation W1806880801 @default.
- W180688080 hasOpenAccess W180688080 @default.
- W180688080 hasPrimaryLocation W1806880801 @default.
- W180688080 hasRelatedWork W180688080 @default.
- W180688080 hasRelatedWork W2077593933 @default.
- W180688080 hasRelatedWork W2141063259 @default.
- W180688080 hasRelatedWork W2397887758 @default.
- W180688080 hasRelatedWork W2471715768 @default.
- W180688080 hasRelatedWork W2975655491 @default.
- W180688080 hasRelatedWork W3193295601 @default.
- W180688080 hasRelatedWork W4242491079 @default.
- W180688080 hasRelatedWork W603999537 @default.
- W180688080 hasRelatedWork W2046122777 @default.
- W180688080 hasVolume "15" @default.
- W180688080 isParatext "false" @default.
- W180688080 isRetracted "false" @default.
- W180688080 magId "180688080" @default.
- W180688080 workType "article" @default.